{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T04:01:27Z","timestamp":1771905687516,"version":"3.50.1"},"reference-count":41,"publisher":"Japan Oil Chemists' Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Oleo Sci."],"published-print":{"date-parts":[[2014]]},"DOI":"10.5650\/jos.ess13082","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T23:08:37Z","timestamp":1389654517000},"page":"177-186","source":"Crossref","is-referenced-by-count":32,"title":["Improved Corneal Toxicity and Permeability of Tranilast by the Preparation of Ophthalmic Formulations Containing Its Nanoparticles"],"prefix":"10.5650","volume":"63","author":[{"given":"Noriaki","family":"Nagai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Hashino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3621","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Diebold, Y.; Jarrin, M.; Saez, V.; Carvalho, E. L. S.; Orea, M.; Calonge, M.; Seijo, B.; Alonso, M. J. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28, 1553-1564 (2007).","DOI":"10.1016\/j.biomaterials.2006.11.028"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Baba, K.; Tanaka, Y.; Kubota, A.; Kasai, H.; Yokokura, S. Nakanishi, H.; Nishida, K. A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolysable dye. J. Control. Release 153, 278-287 (2011).","DOI":"10.1016\/j.jconrel.2011.04.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Li, X.; Zhang, Z.; Li, J.; Sun, S.; Weng, Y.; Chen, H. Diclofenac\/biodegradable polymer micelles for ocular applications. Nanoscale 4, 4667-4673 (2012).","DOI":"10.1039\/c2nr30924f"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Asasutjarit, R.; Thanasanchokpibull, S.; Fuongfuchat, A.; Veeranodha, S. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Int. J. Pharm. 411, 128-135 (2011).","DOI":"10.1016\/j.ijpharm.2011.03.054"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mahmoud, A. A.; El-Feky, G. S.; Kamel, R.; Awad, G. E. A. Chitosan\/sulfobutylether-[beta]-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int. J. Pharm. 413, 229-236 (2011).","DOI":"10.1016\/j.ijpharm.2011.04.031"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ammar, H. O.; Salama, H. A.; Ghorab, M.; Mahmoud, A. A. Nanoemulsions as potential ophthalmic delivery systems for orzolamide hydrochloride. AAPS Pharm. Sci. Tech. 10, 808-819 (2009).","DOI":"10.1208\/s12249-009-9268-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) El-Kamel, A. H. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int. J. Pharm. 241, 47-55 (2002).","DOI":"10.1016\/S0378-5173(02)00234-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sultana, Y.; Aqil, M.; Ali, A. Ion-activated, Gelrite<sup>&reg;<\/sup>-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops. Drug Deliv. 13, 215-219 (2006).","DOI":"10.1080\/10717540500309164"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gupta, H.; Aqil, M.; Khar, R. K.; Ali, A.; Bhatnagar, A.; Mittal, G. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J. Drug Target. 19, 409-417 (2011).","DOI":"10.3109\/1061186X.2010.504268"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Casolaro, M.; Casolaro, I.; Lamponi, S. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery. Eur. J. Pharm. Biopharm. 80, 553-561 (2012).","DOI":"10.1016\/j.ejpb.2011.11.013"},{"key":"11","unstructured":"11) Davies, N. M.; Fair, S. J.; Hadgraft, J.; Kellaway, I. W. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. J. Pharm. Sci. 8, 1039-1043 (1991)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rafie, F.; Javadzadeh, Y.; Javadzadeh, A. R.; Ghavidel, L. A.; Jafari, B., Moogooee, M., Davaran, S. In vivo evaluation of novel nanoparticles containing dexa-methasone for ocular drug delivery on rabbit eye. Curr. Eye Res. 35, 1081-1089 (2010).","DOI":"10.3109\/02713683.2010.508867"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R. Controlled delivery systems for proteins based on poly(lactic\/glycolic acid)microspheres. Pharm. Res. 8, 713-720 (1991).","DOI":"10.1023\/A:1015841715384"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tomoda, K.; Watanabe, A.; Suzuki, K.; Inagi, T.; Terada, H.; Makino, K. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf. B Biointerfaces, 97, 84-89 (2012).","DOI":"10.1016\/j.colsurfb.2012.04.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tomoda, K.; Terashima, H.; Suzuki, K.; Inagi, T.; Terada, H.; Makino, K. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo. Colloids Surf. B Biointerfaces, 92, 50-54 (2012).","DOI":"10.1016\/j.colsurfb.2011.11.016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tomoda, K.; Terashima, H.; Suzuki, K.; Inagi, T.; Terada, H.; Makino, K. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf. B Biointerfaces, 88, 706-710 (2011).","DOI":"10.1016\/j.colsurfb.2011.08.004"},{"key":"17","unstructured":"17) Pfab, T.; Hocher, B. Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug. J. Hypertens., 22, 883-886 (2004)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Suzawa, H.; Kikuchi, S.; Ichikawa, K.; Koda, A. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn. J. Pharmacol., 60, 85-90 (1992).","DOI":"10.1254\/jjp.60.85"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shimizu, T.; Kanai, K.; Kyo, Y.; Asano, K.; Hisamitsu, T.; Suzaki, H. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro. J. Pharm. Pharmacol. 58, 91-99 (2006).","DOI":"10.1211\/jpp.58.1.0011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kagitani, S.; Ueno, H.; Hirade, S.; Takahashi, T.; Takata, M.; Inoue, H. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte\/macrophage infiltration in DOCA\/salt hypertensive rats. J. Hypertens. 22, 1007-1015 (2004).","DOI":"10.1097\/00004872-200405000-00024"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pisella, P. J.; Fillacier, K.; Elena, P. P.; Debbasch, C.; Baudouin, C. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic. Res. 32, 3-8 (2000).","DOI":"10.1159\/000055579"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nagai, N.; Murao, T.; Oe, K.; Ito, Y.; Okamoto, N.; Shimomura, Y. In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T). Yakugaku Zasshi 131, 985-991 (2011).","DOI":"10.1248\/yakushi.131.985"},{"key":"23","unstructured":"23) Yakuji Nippo Ltd. Japanese Pharmacopoeia. Tokyo. Maruzen Co., Ltd, 15 (2006)."},{"key":"24","unstructured":"24) Araki-Sasaki, K.; Ohashi, Y.; Sasabe, T.; Hayashi, K.; Watanabe, H.; Tano, Y.; Handa, H. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest. Ophthalmol. Vis. Sci., 36, 614-621 (1995)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nagai, N.; Ito, Y.; Okamoto, N.; Shimomura, Y. Decrease in corneal damage due to benzalkonium chloride by the addition of sericin into timolol maleate eye drops. J. Oleo Sci. 62, 159-166 (2013).","DOI":"10.5650\/jos.62.159"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Iwata, S.; Osada, Y.; Ogino, H. Aspect on corneal permeability of bupranolol. YAKUGAKU ZASSI 100, 402-406 (1980).","DOI":"10.1248\/yakushi1947.100.4_402"},{"key":"27","unstructured":"27) Rolando, M.; Brezzo, G.; Giordano, P.; Campagna, P.; Burlando, S.; Calabria, G. &ldquo;The Lacrimal System,&rdquo; ed. by Van, Bijsterweld, O. P.; Lemp, M. A.; Spinelli, D. Kagler &amp; Ghedini, Amsterdam, pp. 89-91 (1991)."},{"key":"28","unstructured":"28) Debbasch, C.; Pisella, P. J.; De, Saint, Jean, M.; Rat, P.; Warnet, J. M.; Baudouin, C. Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest. Ophthalmol. Vis. Sci. 42, 2525-2533 (2001)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wilson, W. S.; Duncan, A. J.; Jay, J. L. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br. J. Ophthalmol. 59, 667-669 (1975).","DOI":"10.1136\/bjo.59.11.667"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kuppens, E. V.; de, Jong, C. A.; Stolwijk, T. R.; De Keizer, R. J.; Van, Best, J. A. Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br. J. Ophthalmol. 79, 339-342 (1995).","DOI":"10.1136\/bjo.79.4.339"},{"key":"31","unstructured":"31) Burstein, N. L. Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest. Ophthalmol. Vis. Sci. 19, 308-313 (1980)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) De, Saint, Jean, M.; Debbasch, C.; Brignole, F.; Rat, P.; Warnet, J. M.; Baudouin, C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr. Eye Res. 20, 85-94 (2000).","DOI":"10.1076\/0271-3683(200002)2021-DFT085"},{"key":"33","unstructured":"33) De, Saint, Jean, M.; Brignole, F.; Bringuier, A. F. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest. Ophthalmol. Vis. Sci. 40, 619-630 (1999)."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Guenoun, J. M.; Baudouin, C.; Rat P.; Pauly, A.; Warnet, J. M.; Briqnole, Baudouin, F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest. Ophthalmol. Vis. Sci. 46, 2444-2450 (2005).","DOI":"10.1167\/iovs.04-1331"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Guenoun, J. M.; Baudouin, C.; Rat, P.; Pauly, A.; Briqnole-Baudouin, F. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest. Ophthalmol. Vis. Sci. 46, 4594-4599 (2005).","DOI":"10.1167\/iovs.05-0776"},{"key":"36","unstructured":"36) Debbasch, C.; Brignole, F.; Pisella, P. J.; Warnet, J. M., Rat, P.; Baudouin, C. Quaternary ammoniums and other preservatives\u2019 contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest. Ophthalmol. Vis. Sci. 42, 642-652 (2001)."},{"key":"37","unstructured":"37) Chung, S. H.; Lee, S. K.; Cristol, S. M.; Lee, D. W.; Seo, K. Y.; Kim, E. K. Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol. Vis. 12, 415-421 (2006)."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Mori, K.; Yoshioka, N.; Kondo, Y.; Takeuchi, T.; Yamashita, H. Catalytically Active, Magnetically Separable, and Water-soluble FePt Nanoparticles Modified with Cyclodextrin for Aqueous Hydrogenation Reactions. Green Chem. 11, 1337-1342 (2009).","DOI":"10.1039\/b905331j"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Okamoto, N.; Ito, Y.; Nagai, N.; Murao, T.; Takiguchi, Y.; Kurimoto, T.; Mimura, O. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea. J. Oleo Sci. 59, 423-430 (2010).","DOI":"10.5650\/jos.59.423"},{"key":"40","unstructured":"40) Jansen, T.; Xhonneux, B.; Mesens, J.; Borgers, M. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium. Lens Eye Toxic. Res. 7, 459-468 (1990)."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Kawabata, Y.; Yamamoto, K.; Debari, K.; Onoue, S.; Yamada, S. Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability. Eur. J. Pharm. Sci. 39, 256-262 (2010).","DOI":"10.1016\/j.ejps.2009.12.009"}],"container-title":["Journal of Oleo Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/63\/2\/63_ess13082\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T12:36:38Z","timestamp":1565094998000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/jos\/ess13082?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5650\/jos.ess13082","relation":{},"ISSN":["1345-8957","1347-3352"],"issn-type":[{"value":"1345-8957","type":"print"},{"value":"1347-3352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}